BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5323770)

  • 21. Catecholamines and stress.
    Palkovits M
    Ideggyogy Sz; 2014 Mar; 67(3-4):116-20. PubMed ID: 26118253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic profiling in schizophrenia and major mental disorders.
    Iwamoto K; Kato T
    Neuropsychobiology; 2009; 60(1):5-11. PubMed ID: 19684418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders.
    Lloyd KG; DeMontis G; Broekkamp CL; Thuret F; Worms P
    Adv Biochem Psychopharmacol; 1983; 37():137-48. PubMed ID: 6138947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
    Singh A; Potter A; Newhouse P
    IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modification of urinary catecholamines induced by drugs in schizophrenic patients].
    Ranzato FP
    Acta Neurol (Napoli); 1965; 20(6):675-83. PubMed ID: 5893528
    [No Abstract]   [Full Text] [Related]  

  • 26. [Level of urinary catecholamines in schizophrenic subjects before and after electroshock].
    Nicolosi G; Santoro R; Scarlata S; Ranzato FP
    Acta Neurol (Napoli); 1965; 20(3):308-21. PubMed ID: 5827378
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulatory peptides in animal paradigms of neuropsychiatric illness.
    Diamond BI; Borison RL
    Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
    [No Abstract]   [Full Text] [Related]  

  • 28. Executive functioning in neuropsychiatric disorders: an overview.
    Maurin RK
    Semin Clin Neuropsychiatry; 1999 Jan; 4(1):2-4. PubMed ID: 10229787
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Dimethyltryptamine: its biosynthesis and possible role in mental disease.
    Mandel LR
    Psychopharmacol Bull; 1974 Jul; 10(3):55-6. PubMed ID: 4529087
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarkers in neuropsychiatric diseases.
    Kang UJ
    Neurobiol Dis; 2009 Aug; 35(2):115-6. PubMed ID: 19464368
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical substrates of mental disturbances in Parkinson's disease.
    Agid Y; Ruberg M; Dubois B; Javoy-Agid F
    Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597
    [No Abstract]   [Full Text] [Related]  

  • 32. [Excretion of 5-hydroxyindoleacetic acid and vanilmandelic acid in patients with glaucoma].
    Dienstbier E; Balík J; Duchon J; Fischer O
    Cesk Oftalmol; 1967 May; 23(3):177-86. PubMed ID: 5586682
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuropsychiatric applications of DTI - a review.
    Lim KO; Helpern JA
    NMR Biomed; 2002; 15(7-8):587-93. PubMed ID: 12489105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.
    Krystal JH; D'Souza DC; Petrakis IL; Belger A; Berman RM; Charney DS; Abi-Saab W; Madonick S
    Harv Rev Psychiatry; 1999; 7(3):125-43. PubMed ID: 10483932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endorphins in psychiatry].
    Lajeunesse C; Villeneuve A
    Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkinson's disease--Part 3: Neuropsychiatric symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S59-69. PubMed ID: 18402509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses.
    Sawamura N; Sawa A
    Ann N Y Acad Sci; 2006 Nov; 1086():126-33. PubMed ID: 17185511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biochemistry of mental illness.
    Smith BH; Rosich-Pla A
    Psychosomatics; 1979 Apr; 20(4):278-9, 282-3. PubMed ID: 35811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.